ABSTRACT
Several epidemiological studies indicate that neutrophils, under hyperglycemic conditions, are involved in the perpetuation of the inflammatory status, a characteristic of diabetes mellitus, leading to the production of prodigious quantities of reactive species and the release of neutrophil extracellular traps (NETs). Accordingly, our aim was to study the ability of a panel of 25 structurally related chalcones to modulate human neutrophil oxidative burst and the production of NETs under physiological and high glucose conditions. In general, all chalcones presented similar effects under physiological and high glucose conditions. 2',4-Dihydroxy-3-methoxychalcone (3), here studied for the first time, was the most active (IC50 ≤ 5 µM) on the inhibition of neutrophil oxidative burst, showing the importance of the presence of hydroxy substituents at the C-2' and C-4 positions of the A and B rings, respectively, and a 3-methoxy substituent at B ring of the chalcone scaffold. In the present experimental conditions, NETs release only occurred under high glucose levels. The pentahydroxylated chalcone 1 was the only one that was able to modulate the NETs release. This study provided important considerations about the chalcones' scaffold and their modulatory effect on human neutrophil activities at physiological and high glucose conditions, evidencing their potential use as complementary antidiabetic agents.
Subject(s)
Chalcones/pharmacology , Glucose/pharmacology , Neutrophils/drug effects , Neutrophils/metabolism , Respiratory Burst/drug effects , Adolescent , Adult , Aged , Cell Survival/drug effects , Extracellular Traps/drug effects , Extracellular Traps/metabolism , Female , Humans , Hypoglycemic Agents/pharmacology , Male , Middle Aged , Molecular Structure , Reactive Oxygen Species/metabolism , Spectrophotometry, Ultraviolet , Structure-Activity Relationship , Young AdultABSTRACT
The transition from a fasted to a fed state is associated with extensive transcriptional remodeling in hepatocytes facilitated by hormonal- and nutritional-regulated transcription factors. Here, we use a liver-specific glucocorticoid receptor (GR) knockout (L-GRKO) model to investigate the temporal hepatic expression of GR target genes in response to feeding. Interestingly, in addition to the well-described fasting-regulated genes, we identify a subset of hepatic feeding-induced genes that requires GR for full expression. This includes Gck, which is important for hepatic glucose uptake, utilization, and storage. We show that insulin and glucocorticoids cooperatively regulate hepatic Gck expression in a direct GR-dependent manner by a 4.6 kb upstream GR binding site operating as a Gck enhancer. L-GRKO blunts preprandial and early postprandial Gck expression, which ultimately affects early postprandial hepatic glucose uptake, phosphorylation, and glycogen storage. Thus, GR is positively involved in feeding-induced gene expression and important for postprandial glucose metabolism in the liver.
Subject(s)
Eating , Glucokinase/metabolism , Glucose/metabolism , Liver Glycogen/metabolism , Liver/metabolism , Receptors, Glucocorticoid/metabolism , Animals , Binding Sites , Blood Glucose/metabolism , Dexamethasone/pharmacology , Gene Expression Regulation, Enzymologic , Glucocorticoids/pharmacology , Glucokinase/genetics , HEK293 Cells , Humans , Insulin/pharmacology , Liver/drug effects , Male , Mice, Inbred C57BL , Mice, Knockout , Promoter Regions, Genetic , RNA Polymerase II/metabolism , Rats, Sprague-Dawley , Receptors, Glucocorticoid/agonists , Receptors, Glucocorticoid/genetics , Signal Transduction , Time Factors , Transcription, GeneticABSTRACT
Glucocorticoids (GCs) and the glucocorticoid receptor (GR) are important regulators of development, inflammation, stress response and metabolism, demonstrated in various diseases including Addison's disease, Cushing's syndrome and by the many side effects of prolonged clinical administration of GCs. These conditions include severe metabolic challenges in key metabolic organs like the liver. In the liver, GR is known to regulate the transcription of key enzymes in glucose and lipid metabolism and contribute to the regulation of circadian-expressed genes. Insights to the modes of GR regulation and the underlying functional mechanisms are key for understanding diseases and for the development of improved clinical uses of GCs. The activity and function of GR is regulated at numerous levels including ligand availability, interaction with heat shock protein (HSP) complexes, expression of GR isoforms and posttranslational modifications. Moreover, recent genomics studies show functional interaction with multiple transcription factors (TF) and coregulators in complex transcriptional networks controlling cell type-specific gene expression by GCs. In this review we describe the different regulatory steps important for GR activity and discuss how different TF interaction partners of GR selectively control hepatic gene transcription and metabolism.
Subject(s)
Gene Regulatory Networks , Liver/metabolism , Receptors, Glucocorticoid/physiology , Transcription Factors/physiology , Active Transport, Cell Nucleus , Chromatin Assembly and Disassembly , Enhancer Elements, Genetic/physiology , Forkhead Box Protein O1/physiology , Humans , Receptors, Glucocorticoid/chemistry , Receptors, Glucocorticoid/genetics , STAT5 Transcription Factor/physiology , Signal Transduction/physiologyABSTRACT
The inhibition of carbohydrate-hydrolyzing enzymes, α-amylase and α-glucosidase, is one of the major therapeutic strategies for the treatment of type 2 diabetes mellitus. Chalcones have been recognized for their multiple biological activities, including antidiabetic properties, through unclear mechanisms. In the present work, a panel of chalcones bearing hydroxy, methoxy, methyl, nitro, chloro, fluoro and bromo substituents were evaluated against α-amylase and α-glucosidase activities, most of them for the first time. The results showed that the substitution patterns and the type of substituents of chalcones influence their inhibitory activity. The presence of hydroxy groups at C-2'- and C-4' of the A ring and at C-3 and C-4 of the B ring favors the intended effect. Chalcones holding nitro groups and chloro substituents, together with a hydroxy group in the chalcone scaffold, showed strong inhibition of the α-glucosidase activity. The present study provides related scaffolds that may serve as the basis for the design and synthesis of new structures in order to obtain the ideal antidiabetic chalcone.
Subject(s)
Chalcones/chemistry , Diabetes Mellitus, Type 2/enzymology , Enzyme Inhibitors/chemistry , alpha-Amylases/antagonists & inhibitors , Diabetes Mellitus, Type 2/drug therapy , Drug Discovery , Glycoside Hydrolase Inhibitors/chemistry , Humans , Hypoglycemic Agents/chemistry , Kinetics , alpha-Amylases/metabolism , alpha-Glucosidases/metabolismABSTRACT
Correction for 'A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives' by Sónia Rocha, et al., Food Funct., 2019, DOI: 10.1039/c9fo01298b.